GZGuoli Zhao

Guoli Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guoli Zhao has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Shuoyu Xu

    Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai 200031, China; Shanghai Research Center of Ophthalmology and Optometry, Eye & ENT Hospital, Fudan University, Shanghai 200031, China

    2 shared publications
  • Yi Wang

    Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai 200031, China; Shanghai Research Center of Ophthalmology and Optometry, Eye & ENT Hospital, Fudan University, Shanghai 200031, China

    2 shared publications
  • Dingyi Han

    Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai Research Center for Brain Science and Brain-Inspired Intelligence, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China

    1 shared publication
  • Fang Li

    State Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science Institutes of Brain Science Fudan University Shanghai 200032 China

    1 shared publication
  • Ganggang Zhang

    Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai 200031, China; Shanghai Research Center of Ophthalmology and Optometry, Eye & ENT Hospital, Fudan University, Shanghai 200031, China

    1 shared publication
  • Han Zhou

    State Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science Institutes of Brain Science Fudan University Shanghai 200032 China

    1 shared publication

Latest Publications

  • Engineered hypercompact Fanzor-ωRNA system with enhanced genome editing activity

    by Guoli Zhao, Yuling Liu, Ganggang Zhang, Jingjing Wang, Zhilin Zou, Yi Wang, Shuoyu Xu, Dingyi Han, Zhenyu Xu, Zhongxing Chen, et al.


  • Open Access

    A High‐Fidelity RNA‐Targeting Cas13X Downregulates Connexin43 in Macroglia: A Novel Neuroprotective Strategy for Glaucoma

    by Guoli Zhao, Zhen Li, Ming‐Jie Zhao, Shu‐Ying Li, Qing Xia, Shuoyu Xu, Yu Zhang, Yi Wang, Fang Li, Yu‐Ling Liu, et al.

    Glaucoma is a neurodegenerative disease characterized by the progressive degeneration of retinal ganglion cells (RGCs) and their axons, ultimately leading to irreversible vision loss. Elevated intraocular pressure (IOP) is one of the significant risk factors in glaucoma; however, neurodegeneration continues even after effective IOP management, underscoring the need for neuroprotective therapies. This study investigates the role of connexin43 (Cx43), which is extensively expressed in retinal macroglia, in regulating microglial activation and optic nerve degeneration in glaucoma. A high‐fidelity CRISPR‐Cas13 (hfCas13X) system is employed to selectively target and knock down Cx43 expression in macroglia. The findings reveal that Cx43‐mediated ATP release through hemichannels exacerbates microglial activation and neuroinflammation, thereby contributing to RGC loss. Notably, in a mouse model of chronic ocular hypertension (COH) glaucoma, knocking down Cx43 in macroglia using the hfCas13X system significantly promoted the survival of RGCs and the integrity of the optic nerve, and improved visual function. The hfCas13X system, which offers high‐fidelity RNA editing with minimal off‐target effects, represents a novel and promising therapeutic strategy for glaucoma, highlighting the potential of gene editing technologies in the management of neurodegenerative diseases.


  • Open Access

    Associations between ambient air pollutants exposure and case fatality rate of COVID-19: a multi-city ecological study in China

    by Tiantian Zhang, Guoli Zhao, Li Luo, Yongzhen Li, Wenming Shi

    Background: Environmental factors, including air pollution, can strongly impact on spatio-temporal patterns of infectious diseases outbreak. In this study, we aimed to investigate the association and correlation between ambient air pollutants and case fatality rate (CFR) of the novel coronavirus disease (COVID-19) in China. Methods: Publicly accessible data on COVID-19 average CFR were utilized in the data analysis. The ambient daily air pollutants including fine particulate matter (PM 2.5 ), inhalable particles (PM 10 ) and nitrogen dioxide (NO 2 ) during the period from December 25, 2019 to March 5, 2020 were obtained from National Air Quality Real-time Publishing System of China. Ecological analysis was performed to explore the association and correlation between the cumulative average exposure of ambient air pollutants at different lag days (14 and 28 days) and average CFR in China outside Hubei and cities in Hubei province via model fitting. Results: The average case fatality rate was highest in Wuhan city (4.53%) and the cumulative average exposure of ambient PM 2.5 , PM 10 and NO 2 at lag 28 days was 55.8±12.1μg/m 3 , 66.8±9.2μg/m 3 , 20.7±4.4μg/m 3 , respectively in Hubei province during the study period. Ecological analysis showed that ambient PM 2.5 , PM 10 and NO 2 exposure at both lag 14 and 28 days was positively correlated with average CFR in China outside Hubei (province-level). For city-level analysis in Hubei, significant associations were only found between cumulative ambient NO 2 exposure and average CFR(r=0.693 for Lag0-14, r=0.697 for Lag0-28, respectively) during the same period. Conclusion: Our findings suggested ambient PM 2.5 , PM 10 and NO 2 exposure, especially at 28 lag days, positively associated with the case fatality rate of COVID-19 in China. These results could help provide guidance for identifying potential exposure window and preventing and controlling the epidemic.